The Organ Toxicity of Inhaled Anesthetics
- 1 December 1995
- journal article
- review article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 81 (Supplement) , 51S-66S
- https://doi.org/10.1097/00000539-199512001-00008
Abstract
No abstract availableThis publication has 105 references indexed in Scilit:
- Immunopathogenesis and Treatment of Halothane HepatitisClinical Immunotherapeutics, 1995
- Identification of Cytochrome P450 2E1 as the Predominant Enzyme Catalyzing Human Liver Microsomal Defluorination of Sevoflurane, Isoflurane, and MethoxyfluraneAnesthesiology, 1993
- Plasma Inorganic Fluoride With Sevoflurane AnesthesiaAnesthesia & Analgesia, 1992
- Plasma Inorganic Fluoride Concentrations During and After Prolonged (>24 h) Isoflurane SedationAnesthesia & Analgesia, 1991
- A metabolite of halothane covalently binds to an endoplasmic reticulum protein that is highly homologous to phosphatidylinositol-specific phospholipase C-α but has no activityBiochemical and Biophysical Research Communications, 1991
- Detection of antibodies to a halothane metabolite hapten in sera from patients with halothane-associated hepatitisJournal of Hepatology, 1989
- Halothane hepatitis: Attempt to develop an animal modelInternational Journal of Immunopharmacology, 1987
- Antibodies to the Surface of Halothane-Altered Rabbit Hepatocytes in Patients with Severe Halothane-Associated HepatitisNew England Journal of Medicine, 1980
- Resistance of Isoflurane to Biotransformation in ManAnesthesiology, 1975
- Anesthesia and the LiverAnesthesiology, 1964